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In recent decades, there has been a growing interest in the use of herbs and herbal medici-
nal products, both in developing and developed countries. While electronic medium has 
become a more and more important tool for presenting information about health-related 
issues, several studies demonstrated that the internet often contains inaccurate and/or mis-
leading information. In our study we assessed 30 Hungarian websites and 2 cellphone ap-
plications intended for public use and evaluated the quality and credibility of the informa-
tion presented about medicinal plants recommended. It was found that websites showed 
very diverse safety: most websites gave mixed information, that is, some medicinal herbs 
and their potential hazard were properly described, while others were not. There were, 
however, websites, which completely missed to give information about any potential haz-
ard. As credibility of public websites can be in most cases questioned, it is strongly recom-
mended for potential users to consult more than one source of information.
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INTRODUCTION
In recent decades, the popularity of herbs and herbal medicinal prod-
ucts has been growing both in developing and developed countries, including 
Hungary. In developed countries, many patients or consumers are seeking 
herbal therapy assuming that it will promote healthier living (Ekor 2014).
However, while there is a quite general belief that herbal medicines are 
safe because they are “natural” (White et al. 2014), traditional is not neces-
sarily safe. There are numerous risk factors associated with the use of herbal 
medicinal products, including unexpected toxicity (Jordan et al. 2010).
Due to the continuous development of analytical technology, identification 
and detection of secondary metabolites have considerably improved (Masullo 
et al. 2015), revealing the presence of potentially toxic bioactive compounds 
such as hepatotoxic pyrrolizidine alkaloids (PAs) (Kristanc and Kreft 2016a). 
Wiesner and Knöss (2014) discuss that a complete chemical profile should be 
given, including not only the major ingredients but all bioactive compounds.
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Unexpected toxicity also occurs in case of misidentification (Kristanc and 
Kreft 2016b), adulteration (Techen et al. 2014) or contamination. Contamina-
tion can be observed in polluted habitats, where the plants accumulate heavy 
metals and/or polyaromatic hydrocarbons (PAHs), either from contaminated 
soil or from atmospheric deposition (reviewed by Tripathy et al. 2015). Pes-
ticide residues have also been detected (Zhang et al. 2012). Herbs or herbal 
preparations can be contaminated with mycotoxins, which might cause ad-
verse human health effects (Ashiq et al. 2014). In some cases, even parasites 
have been found in herbal preparations (Mazzanti et al. 2008). Phytochemical 
variability might also be an issue: chemical composition and thus mode of 
action of the plant can be influenced by environmental factors (reviewed by 
Dhami and Mishra 2015).
Clinical reports prove that interactions with other drugs, either pharma-
ceutical or herbal, can pose actual human health hazard (e.g. Izzo and Ernst 
2001, Jordan et al. 2010).
For the public, diverse information sources are available on the collec-
tion, cultivation, identification, mode of action and preparation of herbs. They 
involve books, websites, lectures (also accessible on the internet), organised 
excursions and/or visits to botanical gardens. Electronic medium has become 
a more and more important tool for presenting information about health-re-
lated issues, including medicinal plant databases (Ningthoujam et al. 2012). 
For example, in the U.S., sixty-one percent of adults seek health information 
online (Kitchens et al. 2014).
Public websites, however, might lack quality assurance; in other words, 
the information provided by them might have been compiled without actual 
scientific review. Bearing in mind the growing interest towards herbal medic-
inal products and the potential hazards mentioned, the purpose of the study 
was to evaluate the credibility of readily available Hungarian websites about 
medicinal herbs. Another aspect of the evaluation was whether the database 
included protected species, indicating their legal status.
METHODS
Google-based search was done, using the selective key words: medicinal 
plants; everyday medicinal plants; common medicinal plants (in Hungarian: 
gyógynövények; mindennapi gyógynövények/gyógynövényeink; gyakori 
gyógynövények). Websites were evaluated in order of appearance. Exclusion 
criteria were:
 – commercial ads (for example, advertising herbal products, books, training 
courses, etc.);
 – simple compilation of publications;
 – only a narrow collection of selected herbs, e.g. for losing weight.
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Websites were preferred which included a list of recommended medici-
nal herbs with:
 – description (including taxonomy, habitat or other ecological traits);
 – information on collection (methods, season, etc.);
 – mode of action;
 – suggested use, mode of preparation;
 – additional information (e.g. photo, potential risks, etc.).
Websites were evaluated based on:
 – number of potentially hazardous plants per website;
 – number of potentially hazardous plants per website inadequately descri-
bed;
 – number of protected species per website;
 – number of protected species per website inadequately described (the web-
site did not mention the protected status of the plant and did not inform the 
users that collection of any part of the specimen was strictly forbidden by 
Hungarian national legislation).
Plants included in the list of the (Hungarian) National Institute of Phar-
macy and Nutrition (OÉTI 2013) were considered potentially toxic/hazardous 
(Table 1). In case of any doubt, community herbal monographs or public state-
Table 1
List of hazardous plants, which (1) were included in at least one of the websites accessed 
and (2) are included in the OÉTI list
Name of the plant Active ingredients responsible for potential hazard
Acorus calamus asarone
Adonis sp. cardenolide glycoside, adonitoxin
Alkanna tinctoria pyrrolizidine alkaloids, likopsamin
Angelica archangelica furocoumarins
Arctostaphylos uva-ursi quinone, arbutin, metlarbutin
Aristolochia sp. aristolochid acid and derivatives
Artemisia absinthium α-thujone
Asarum europaeum β-asarone
Berberis vulgaris isoquinoline alkaloids, berberine
Bryonia sp. cytotoxic cucurbitacin
Chelidonium majus isoquinoline alkaloids, chelidonine, protopine
Cimicifuga racemosa actein, 27-deoxi-actein, cimicifugoside
Colchicum sp. alkaloids, colchicine
Conium maculatum alkaloids: coniine, coniceine
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Table 1 (continued)
Name of the plant Active ingredients responsible for potential hazard
Convallaria majalis cardenolide glycosides, convallatoxin, convallozid
Datura sp. tropane alkaloids: atropine, scopolamine
Digitalis sp. cardenolide glycosides, digitoxin, lanatoside
Dryopteris filix-mas phloroglucin derivatives
Ephedra sp. phenilalkilaminalkaloids, ephedrine, norephedrine
Euonymus sp. evonine type alkaloids, evonin; cardenolide, evonoside
Euphorbia sp. tiglinane, ingenane and daphnane type phorbol esters
Fumaria officinalis isoquinoline alkaloids, scoulerine, protopine
Genista tinctoria alkaloids: anagirin, cytisine, sparteine; izoflavone, genistein
Gratiola officinalis triterpene glykoside, graciozid; cucurbitacin
Hedera helix saponins, α(alpha)-hederin
Helleborus sp. alkaloids, celliamine, sprintilline; cardenolide glycoside, hel-
lebrin; toxic saponins, helleborin
Hyoscyamus sp. tropane alkaloids, hyoscyamine, scopolamine
Hypericum perforatum naphtodiantrones, hypericin, pseudohypericin
Leonorus cardiaca diterpenes of labdane skeleton lactones, leocardin; alkaloids
Lycopodium clavatum alkaloids, lycopodin
Melilotus officinalis coumarin
Oenanthe sp. oenantotoxin, apiol, myristicin
Paeonia officinalis –
Petasites hybridus (un/) insaturated pyrrolizidine alkaloids
Pulsatilla sp. protoanemonin, ranunculin
Rhamnus frangula hydroxyanthraquinone, frangulin, glucofrangulin
Scopolia sp. tropane alkaloids, atropine, scopolamine
Senecio sp. (un/) insaturated pyrrolizidine alkaloids, senecionine
Solanum dulcamara steroidal alkaloids and saponins
Symphytum sp. pyrrolizidine alkaloids
Taxus baccata diterpene pseudoalkaloids, taxine A and B
Teucrium chamaedrys neo-clerodane, teucrium lactones
Tussilago farfara pyrrolizidine alkaloids
Veratrum album steroidal alkaloids, protoveratrin A and B
Viscum album Viscum lectin I–III; viscotoxin
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ments (reviewed by Chinou 2014) were consulted. In case of Fumaria officinalis 
for example, the OÉTI list states that: “not enough data are available to assess 
safety”. The Community Monograph (HMPC 2011a) gives special warnings 
and precautions for use, such as contraindications in case of biliary diseases 
and hepatitis.
Description was considered safe if the website mentioned the potential 
toxicity of the herb, or gave another special warnings, such as potential con-
traindications, or safe dose (e.g. in case of Artemisia absinthium a daily intake 
of 3.0 mg/person is acceptable for a maximum duration of use of 2 weeks, due 
to the thujone content (HMPC 2009)).
Legal status of the species was given according to the 13/2001 (V. 9.) KöM 
Decree.
RESULTS
Altogether 30 websites and 2 cellphone applications were assessed. Ta-
ble 2 gives a summary about (1) number of potentially hazardous plants per 
website; (2) number of potentially hazardous plants per website with lacking/
misleading information about the potential hazards; (3) number of protected 
species per website and (4) number of protected species per website with lack-
ing/misleading information about the legal status.
Considering potential risk of herbs, credibility and safety of websites 
varied to a high extent. The lowest category of safety and credibility is repre-
sented by websites where no information was given about potential hazards 
(e.g. W1, W10 and W11). Most websites gave mixed information: some me-
dicinal herbs and their potential risks were properly described while others 
Table 2
Number of potentially hazardous plants per website (PH); number of potentially hazard-
ous plants per website with missing/incorrect information on the potential hazard (PH–); 
number of protected species per website (PS); number of protected species per website 
with missing/incorrect information on the legal status (PS–); number of all taxa included; 
short description of the website. W1–W30: Websites 1–30; App1–App2: cellphone ap-
plications 1–2
Web-
site
PH PH– PS PS– No of all 
taxa
Short description
W1 7 7 2 0 31 advices in everyday health issues
W2 10 0 5 3 102 reliable relic of medical plants
W3 2 1 0 0 15 gives alternative medicine option
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Table 2 (continued)
Web-
site
PH PH– PS PS– No of all 
taxa
Short description
W4 3 1 0 0 53 list of herbs recommended for different 
illness
W5 1 1 0 0 9 helping in everyday health
W6 23 3 10 2 183 herbs a–z, application, therapy, property, 
cultivation
W7 11 4 7 0 90 collection of most important herbs
W8 1 1 1 1 207 collection of herbs, herbal teas and spices
W9 14 3 7 5 49 showing the healing power of nature
W10 9 9 4 2 10 description of herbal products
W11 7 7 2 0 31 suggests that ‘every complaint can be 
cured by a herb’
W12 25 13 16 15 246 lexicon of herbal plants
W13 3 2 0 0 32 introduction to the world of herbs
W14 4 0 1 0 55 herbal teas and promotion
W15 6 8 0 0 49 general uses of herbs
W16 11 5 3 3 109 phytotherapy guide
W17 23 0 1 0 119 description of herbs
W18 0 0 0 0 18 description of herbs
W19 5 2 4 3 170 modern use of herbs
W20 13 3 6 3 239 description of herbs
W21 1 1 0 0 53 description of herbs
W22 1 0 0 0 16 the most common herbs around the house
W23 17 10 7 0 73 collection of herbs
W24 7 4 3 1 72 schematic overview of herbs, herbs and 
edible (wild) plants
W25 4 0 0 0 23 description of herbs
W26 14 5 4 4 99 effects of herbs
W27 3 1 0 0 94 description of herbs
W28 38 25 18 17 240 description of herbs
W29 32 18 21 1 796 general uses of herbs
W30 24 5 13 2 700 description of herbs
App1 22 6 3 1 187 description of herbs
App2 6 0 2 0 183 description of herbs
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were not (e.g. W6 which included 23 potentially hazardous species, but only 3 
were improperly described or W12, which included 25 potentially hazardous 
species, but gave inappropriate description for approximately half of them, 
13). It is interesting to note that W28 and W29 covered the widest range of 
potentially hazardous plants (38 and 32, respectively) and also, number of 
inappropriately described plants was the highest in their case, 25 and 18, re-
spectively. Of cellphone applications, the wider database (App1) included 22 
potentially hazardous species, but description of only 6 were found as inap-
propriate. The other included only 6 such species, but provided correct infor-
mation on the potential hazard.
Considering the protected status of medicinal herbs, websites also varied 
to a great extent. For example, W12 included 16 protected species and 15 were 
improperly described; similarly, W28 included 18 protected species and for 17 
of them, no information was provided about the legal status. On the contrary, 
W29 included 21 protected species and the conservation status of only 1 of 
them was missing.
DISCUSSION
As the number of people consulting the Internet in health-related issues 
is continuously rising, more and more studies attempt to assess the credibility 
of websites (e.g. Gao et al. 2015, Lederman et al. 2014).
Molassiotis and Xu (2004) evaluated safety issues of web-based informa-
tion about herbal medicines in the treatment of cancer. In their study, a scor-
ing system was applied to give a quantitative estimation about overall safety 
of the website. They concluded that based on these scores, “the safety of the 
web-based information on herbs in the treatment of cancer was low”. While 
in our study commercial websites (advertising some herbal products) were 
excluded, the assessment of Molassiotis and Xu included such websites and 
found that they had the lowest safety scores.
In parallel with the growing interest in herbal medicinal products, there 
is an increasing concern about their safety on institutional level. The World 
Health Organisation (2004) recommends the safety monitoring of herbal 
medicines/traditional medicines. It might especially be useful in developing 
countries, where approximately 80% of the population relies on herbal rem-
edies (Neergheen-Bhujun 2013). However, more and more studies prove that 
even such herbs, which have a long tradition can cause negative effects. For 
example, Haq (2004) in his review gives an extensive list of these herbs, which 
include ginkgo (Ginkgo biloba) and ginseng (Panax ginseng). Assessment of ad-
verse effects is based on patients’ reports and/or animal toxicological tests.
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Adverse effects of alternative medicine have already been reported in 
Europe. Jacobsson et al. (2009) covered an approximately 20-year period (be-
tween 1987 and 2006) and found 967 suspected adverse reactions related to 
different complementary and alternative medicine (CAM) products. Surpris-
ingly, the most reported cases (8.1%) were connected to purple coneflower 
(Echinacea purpurea), an herb, which is non-native in Hungary, but is widely 
used. Medicinal herbs might also be used as Plant Food Supplements (PFS). In 
the framework of the European Project PlantLIBRA, a survey was performed 
involving over 2300 adults from 6 countries (Finland, Germany, Italy, Roma-
nia, Spain and UK). Complaints regarding adverse reactions were also as-
sessed. Causality was likely in 56 out of 87 cases (Restani et al. 2016).
It is not the main intention of this paper to discuss all potentially tox-
ic/hazardous plants included in the websites assessed in details. However, 
some plants are taken as examples. Comfrey (Symphytum officinale L., family 
Boraginaceae) is known to contain pyrrolizidine alkaloids (PAs), which have 
hepatotoxic effect. Allgaier and Franz (2015) review the regulations concern-
ing the human exposure to PAs in herbal medicine products: in most cases, 
daily exposure is limited and/or the maximum period for its application is 
given (it is interesting to note, however, that the EMA public statement (EMA 
2014) does not discriminate between oral and dermal exposure). As the above 
mentioned list of the Hungarian National Institute of Pharmacy and Nutrition 
(OÉTI 2013) clearly prohibits its use, we assessed how reliable information is 
given by the websites presented in this study. Of the 30 websites, 18 included 
comfrey and 5 provided misleading information.
The use of another potentially hepatotoxic plant, greater celandine (Che-
lidonium majus L.) was causally related to liver injury according to European 
case reports (Teschke et al. 2012a) and hepatitis (Moro et al. 2009). All these 
authors emphasize that concern should be increased about the safety of oral 
use of C. majus. In our study, the plant was included in 12 websites, 7 of them 
gave proper warning. In general, reported cases of herbal hepatotoxicity are 
the most often discussed and reviewed (Ernst 2003, Stickel and Shouval 2015, 
Teschke et al. 2012b).
Another example is St. John’s wort (Hypericum perforatum), which was 
included in most of the websites, 25. Roughly 50% (13) gave proper safety 
instructions. The plant is most valued for treating depression and other mood 
disorders; exact modes of action are reviewed by Klemow et al. (2011). The 
main active compound is the photodynamic active plant pigment hypericin. 
Phototoxic symptoms (“hypericism”) have been observed in grazing animals 
consuming large amounts of St. John’s wort, however, standard dosage used 
in case of mood disorders does not produce phototoxic symptoms in humans 
(Schempp et al. 2002).
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In addition to its antidepressant capacity, St. John’s wort is used for the 
topical treatment of superficial wounds such as scars and burns. Schempp et 
al. (2000) assessed the photosensitizing capacity of topical application of Hy-
pericum oil (hypericin 110 µg/mL) and Hypericum ointment (hypericin 30 µg/
mL) on volunteers. While no severe phototoxic potential was demonstrated, 
an increase of the erythema-index could be detected following the treatment 
with the Hypericum oil.
However, clinical trials prove that much higher risk is posed by the plant 
via the interaction with certain drugs, affecting their systemic bioavailability 
(Izzo and Ernst 2001, Mills et al. 2004). For example, reduced plasma concen-
tration of antiretroviral and anticancer drugs was reported (Borrelli and Izzo 
2009).
Recognising the potential risks associated with the use of herbal medici-
nal products (HMPs), Directive 2004/24/EC was issued in the European Un-
ion (Knöss and Chinou 2012). Naturally, its main field is the regulation of 
the market of such products. The public can be informed about the safe use 
or potential risk of herbs and herbal products by Community herbal mono-
graphs, Community list entries or public statements (PS) (reviewed by Chi-
nou 2014). Community monographs are issued by the Committee on Herbal 
Medicinal Products, while Community list entries are published by the Eu-
ropean Commission. Both Monographs and List entries provide a final and 
complete assessment of the safety and traditional use, but Community list 
entries are regarded as legally binding (Peschel 2014). Public statements have 
been published when the assessment could not be completed due to lack of 
data or safety issues emerged. For example, the PS on C. majus formulates the 
problems: gives chemical description of alkaloid content and also summarises 
reported adverse drug reactions. It also gives a conclusion, including the fol-
lowing statements: “the benefit-risk assessment of oral use of Chelidonium ma-
jus is considered negative with respect to the establishment of a community 
monograph” and “safer herbal medicinal products are available in the indica-
tion in question” (HMPC 2011b).
As a conclusion, it has been revealed by our study that the websites eval-
uated showed very diverse credibility, so in case of any doubt it is strongly 
recommended for potential users to consult more than one sources of infor-
mation. Elvin-Lewis (2001) in an excellent work (Should we be concerned 
about herbal remedies) summarises all potential risks and formulates some 
useful guidelines. These include, among others, the following points: “be in-
formed, seek out unbiased, scientific sources” and “know benefits and risks 
and potential side effects”.
On the other hand, however, websites and cellphone applications are 
flexible in a way that their content can be continuously reviewed and im-
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proved. It should be very important in the case of cellphone applications, 
which will most possibly gain wider publicity in the near future.
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